Ana Luisa Neves
Ana Luisa Neves, MD MSc PhD, is a Clinical Senior Lecturer in Digital Health and Director of the Global Digital Health Unit at Imperial College London (UK), and a Visiting Scholar at Ariadne Labs. She is also currently the Chair of the Working Party on eHealth, World Organisation of General Practice.
Dr Neves is passionated about the development, implementation and evaluation of evidence-based digital solutions, with the ultimate aim to improve safety, quality and equity of care.
She currently leads two research programs funded by the National Institute for Health and Care Research (NIHR), serving as theme lead for Northwest London NIHR Patient Safety Research Collaboration and for NIHR Northwest London Applied Research Collaboration. These programs of work focus, respectively, on 1) the evaluation of the safety implications of digitally-enabled care and 2) implementation of digital interventions to improve the care of people with long-term conditions (i.e., health outcomes, patient experience and healthcare efficiency).
In recent years, Dr Neves oversaw the academic support to the WHO Global Patient Safety Collaborative, a multi-national consortium designed to strengthen leadership, capacity building and research development in low and middle-income countries. In what concerns teaching activities, she is the Module Lead for Digital Health in the Masters Public Health and Global Master of Public Health at Imperial College London. She is also Module Lead (Health Data Collection and Principles of Health Data Science) at the PhD Programme in Health Data Science at University of Porto, where she holds a post as Invited Assistant Professor. She coordinated and participated in several research studies and services, which resulted in >60 published peer-review articles (h-index 28).
Ana qualified in Medicine and completed specialist training in General Practice, and has worked as a medical doctor in both high- and low-income countries. She undertook academic and research placements at Institut National de la Santé et Recherche Médicale (Paris) and at Cambridge Health Alliance (Boston), before obtaining her PhD in Clinical Medicine at Imperial College London (2018). In 2024, she has completed the Global Health Leaders Program at Harvard University.